Top Markets
#1 The Black Bull The Black Bull +22.59%
#2 EXOD EXOD +22.08%
#3 SSV Network SSV Network +21.25%
#4 XPIN Network XPIN Network +21.09%
#5 Useless Coin Useless Coin +20.60%
#6 Ore Ore +20.14%
#7 GALA GALA +19.48%
#8 Wrapped XPL Wrapped XPL +18.69%
#9 Plasma Plasma +18.68%
#10 Unit Plasma Unit Plasma +18.68%
Coin of the day
The Black Bull The Black Bull
Settings
Language
ENGLISH
Currency
USD
Theme
Orexo AB Orexo AB

Orexo AB

ORX
Rank in Stocks #24964
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Share Price
$1.56
Market Cap
$54.77M
Change (1 day)
-0.43%
Change (1 year)
-29.25%
Country
SE
Trade Orexo AB (ORX)

Category

Healthcare
Earnings for Orexo AB (ORX)
Earnings in 2026 TTM: 0
According to Orexo AB latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Orexo AB from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK